Chris Chai
InvestorVenture Partner at SR One Capital Management
San Francisco Bay Area
Writes $500K – $5M checks · typically $2.8M
About
Chris Chai is an Operating Partner at SR One who advises portfolio companies on financing strategy and their engagement with Wall Street. He has more than 20 years of experience in biotech executive management and investment banking, having served as CFO at Principia Biopharma and MAP Pharmaceuticals and in treasury and investor relations at CV Therapeutics, and previously worked in investment banking at JP Morgan. He holds a BS in Operations Research and Industrial Engineering from Cornell University.
Invests in
Biotech
Experience
- SR One Capital ManagementVenture Partnercurrent2021 — presentSan Francisco Bay Area
- SurrozenBoard Membercurrent2021 — presentSan Francisco Bay Area
- TranscripTxBoard Member2016 — 2020
- Principia BiopharmaChief Financial Officer2013 — 2020San Francisco Bay Area
- MAP PharmaceuticalsChief Financial Officer2006 — 2013San Francisco Bay Area
- CV TherapeuticsVice President, Treasury and Investor Relations1998 — 2006San Francisco Bay Area
- PATHWAYS HOSPICE FOUNDATION INCBoard Member2000 — 2004San Francisco Bay Area
- J.P. MorganInvestment Banking Associate - Healthcare1995 — 1998San Francisco Bay Area
- J.P. MorganInvestment Banking Associate1992 — 1995New York City Metropolitan Area
- J.P. MorganAudit Officer1988 — 1992New York City Metropolitan Area
Education
- Cornell UniversityBachelor of Science - BS, Operations Research and Industrial Engineering
Same school
Also attended Cornell University509
+ 503 more
Shared employers
Also worked at Principia Biopharma2
Also worked at CV Therapeutics3
Also worked at J.P. Morgan689
+ 683 more
Investments
Board seats
Surrozen, Inc.
Per the firm's website.
Colleagues at SR One Capital Management
Network5
Investors connected to Chris in public investor directories — a warm-intro map.